Lincoln Capital Corp’s Eli Lilly LLY Stock Holding History

Lincoln Capital Corp’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Sell	210 -87	-29%	-$88.9K	0.08%	90
2026 Q1	$273K	Buy	+297	New	+$301K	0.1%	78
2025 Q2	–	Sell	-281	Closed	-$232K	–	94
2025 Q1	$232K	Buy	281 +21	+8%	+$17.5K	0.1%	81
2024 Q4	$201K	Sell	260 -89	-26%	-$73.7K	0.08%	82
2024 Q3	$309K	Buy	349 +10	+3%	+$8.99K	0.13%	69
2024 Q2	$307K	Buy	339 +1	+0.3%	+$800	0.13%	66
2024 Q1	$263K	Buy	+338	New	+$241K	0.12%	62
2018 Q2	–	Sell	-16,489	Closed	-$1.27M	–	50
2018 Q1	$1.27M	Sell	16,489 -2,067	-11%	-$166K	1.18%	29
2017 Q4	$1.57M	Buy	+18,556	New	+$1.58M	1.34%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lincoln Capital Corp's LLY Position: Q2 2026 in Review

Lincoln Capital Corp reduced its Eli Lilly (LLY) stake by 29% in Q2 2026, selling an estimated $88.9K and leaving 210 shares worth $252K. The position accounts for 0.08% of the portfolio, ranked #90.

Lincoln Capital Corp first reported a position in LLY in Q4 2017 and has held it in 9 quarters since. The position peaked at $1.57M in Q4 2017. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Lincoln Capital Corp held 210 shares of Eli Lilly worth $252K as of Q2 2026.
Lincoln Capital Corp sold 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
Eli Lilly made up 0.08% of Lincoln Capital Corp's portfolio in Q2 2026, its #90 holding.
Lincoln Capital Corp first reported a position in Eli Lilly in Q4 2017 and has held it in 9 quarters since.
Lincoln Capital Corp's Eli Lilly position peaked at $1.57M in Q4 2017.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lincoln Capital Corp's 13F filing for Q2 2026, filed 16 Jul 2026.